Receptors as defined by their pharmacological properties. In: Molecular properties of drug receptors.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001692:Biological Transport; D008725:Bis-Trimethylammonium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D004336:Drug Antagonism; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008956:Models, Chemical; D009020:Morphine / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000777:Anesthetics; D008725:Bis-Trimethylammonium Compounds; D002395:Catecholamines; D006634:Histamine H1 Antagonists; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D010277:Parasympathomimetics; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics; D009020:Morphine